| | Index Performance | Index | Sensex | Nifty | Open | 15,344.02 | 4,528.85 | High | 15,344.02 | 4,532.90 | Low | 14,910.52 | 4,339.75 | Today's Cls | 14,935.77 | 4,345.85 | Prev Cls | 15,550.99 | 4,528.85 | Change | -615.22 | -183.00 | % Change | -3.96 | -4.04 | | | Market Indicators | Top Movers (Group A) | Company | Price (Rs) | % chg | Gainers | United Phosphorus | 319.50 | 4.12 | Ingeroll Rand | 345.00 | 2.25 | Ipca Lab | 715.00 | 1.76 | Nestle | 1,203.00 | 1.15 | Nalco | 265.80 | 1.06 | Losers | HDIL | 515.50 | -10.01 | GMR Infra | 756.90 | -9.80 | HCL Infosys | 182.50 | -8.93 | Parsvnath Developers | 325.85 | -8.89 | ACC | 965.90 | -8.87 | | Market Statistics | - | BSE | NSE | Advances | 501 | 97 | Declines | 2,109 | 1,026 | Unchanged | 41 | 14 | Volume(Nos) | 31.00cr | 41.69cr | | | | | Market Commentary | | Sensex plummets 615 points | Weakness in the global indices took a heavy toll on the market and the Sensex shed 3.96% on across-the-board selling pressure. | The market witnessed the second crash today after witnessing a fall of 541 points on Friday. Following a steep fall in global stock markets led by fears of a | | | credit crunch in the US, the Sensex resumed on a bearish note at 15,344, 207 points below its last close of 15,551. By mid-morning trades the Sensex shed over 500 points on across-the-board selling pressure. The market started to deteriorate further, towards the close, as fresh bout of selling saw the Sensex plummet over 600 points and touch the day's low of 14,911. Despite registering smart gains in the last session, the Sensex dropped 3.96% and was down 615 points for the day at 14,936. The Nifty shed 4.04% and was down 183 points at 4,346. The market breadth was heavily tilted in favour of the losers as 2,109 stocks declined, 501 stocks advanced and 41 stocks remained unchanged on the BSE. All the sectoral indices were battered on the BSE. The BSE Realty index lost heavily and dropped 6.64% followed by the BSE Metal index (down 4.81%), the BSE CG index (down 4.69%), the BSE Oil & Gas index (down 4.40%), the BSE CD index (down 3.99%) and the BSE Bankex index (down 3.93%). The second-rung benchmark indices the BSE mid-cap index and the BSE small-cap index tanked over 3% each. None of the 30 Sensex stocks managed to end in the green. Among the major losers ACC tanked by 9.05% at Rs964. Reliance Energy slumped by 7.08% at Rs737, Hindalco shed 6.44% at Rs159, Ranbaxy crumbled by 5.67% at Rs368. Reliance communication dropped 5.05% at Rs531, Tata Steel slipped by 5.04% at Rs622, Reliance plunged 4.98% at Rs1,798 and M&M fell by 4.87% at Rs694. Other front-line stocks also declined by around 3-4% each. | | Movers & Shakers | - Logix Microsystems tumbled despite acquiring ReckonUp,
a CRM product from Prize Corporation. - Alok Industries slipped despite signing an exclusive license agreement with AISLE 5 to add "aworld" and "Cotton + Clay" in its portfolio of lifestyle brands.
| | | Realty stocks took a heavy pounding. Housing Development & Infrastructure plunged by 10.01% at Rs516, Indiabulls Real Estate tumbled by 9.33% at Rs501, Parsvanath Developers lost 8.89% at Rs326, Peninsula Land by 8.89% at Rs326 and Unitech declined by 7.96% at Rs514. Sobha Developers, Ansal Infrstructures, Mahindra Gesco and DLF crashed around 4-5% each. Metal stocks, too, were hammered on the bourses. Shree Precoated Steels slumped by 9.62% at Rs334, Welspun Gujrat dropped 6.45% at Rs234 and Bhushan Steel fell by 6.23% at Rs659. Over 1.35 crore RNRL shares changed hands on the BSE followed by IFCI (1.08 crore shares), Everonn Systems (71.77 lakh shares), Industrial Investment Trust (54.47 lakh shares) and Bella Steel (54.04 lakh shares). Value-wise Everonn Systems registered a turnover of Rs367 crore on the BSE followed by Reliance Industries (Rs289 crore), Reliance Energy (Rs203 crore), SBI (Rs170 crore) and Reliance Communication (Rs161 crore). | | | | | | | | European Indices at 16:15 IST on 01-08-2007 | | | Index | Level | Change (pts) | Change (%) | FTSE 100 | 6240.90 | -119.20 | -1.87 | CAC 40 Index | 5624.73 | -126.35 | -2.20 | DAX Index | 7471.79 | -112.35 | -1.48 | | | | | | | | | | | Asian Indices at close on 01-08-2007 | | | Index | Level | Change (pts) | Change (%) | Nikkei 225 | 16870.98 | -377.91 | -2.19 | Hang Seng | 22455.36 | -729.58 | -3.15 | Kospi Index | 1856.45 | 76.82 | 3.97 | Straits Times | 3431.71 | -115.95 | -3.27 | Jakarta Composite Index | 2256.31 | -92.37 | -3.93 | | | | | | | | To know more about our products and services, click here. | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report. The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
No comments:
Post a Comment